Shares of Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ – Get Free Report) were up 0.4% during mid-day trading on Thursday . The company traded as high as $5.4599 and last traded at $5.45. Approximately 198,556 shares were traded during trading, a decline of 4% from the average daily volume of 205,918 shares. The stock had previously closed at $5.43.
Health Sciences Acquisitions Co. 2 Stock Performance
The company has a 50 day moving average price of $4.47 and a 200 day moving average price of $4.29.
Health Sciences Acquisitions Co. 2 Company Profile
Health Sciences Acquisitions Co 2 is a Delaware‐incorporated special purpose acquisition company (SPAC) established to pursue a business combination with a company in the health sciences sector. Listed on the Nasdaq under the ticker HSAQ, the firm completed an initial public offering in early 2021, raising capital through the sale of units comprised of common stock and warrants.
As a blank‐check vehicle, Health Sciences Acquisitions Co 2 does not engage in commercial operations; rather, it focuses exclusively on identifying and combining with a private company operating in biotechnology, pharmaceuticals, medical devices or related life sciences fields.
Featured Articles
- Five stocks we like better than Health Sciences Acquisitions Co. 2
- Optical Cable Corporation Is Starting to Get the Market’s Attention
- Oil Above $100 Is Creating a New Opportunity Beyond the Major Producers
- Is Nike’s Index Demotion a Warning or a Buying Opportunity?
- American Eagle Goes on Sale: Is It Time to Buy?
Receive News & Ratings for Health Sciences Acquisitions Co. 2 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Sciences Acquisitions Co. 2 and related companies with MarketBeat.com's FREE daily email newsletter.
